AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 186090
Drug: Noradrenaline (vasoconstrictor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Noradrenaline (vasoconstrictor doses) with propranolol or practolol
Trial: 20495139
Drug: Phenylephrine 25
RxNorm normalized name: phenylephrine 25 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenylephrine 25 μg/min
Trial: 16606867
Drug: Aggressive risk
RxNorm normalized name: Hep B, adolescent/high risk infant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aggressive risk factor modification strategy (targeted treatment of hypertension, dyslipidaemia, homocysteine, haemoglobin and phosphate)
Trial: 12568834
Drug: Tacrine (initial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tacrine (initial dose of 40 mg/day increased up to 160 mg/day)
Trial: 11342422
Drug: PMitCEBO (mitoxantrone,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PMitCEBO (mitoxantrone, 7 mg/m2 IV on day 1)
Trial: 11342422
Drug: PAdriaCEBO (adriamycin,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PAdriaCEBO (adriamycin, 35 mg/m2 IV on day 1)
Trial: 7840553
Drug: Dapsone monotherapy
RxNorm normalized name: Dapsone
DrugBank: Dapsone (DB00250)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dapsone monotherapy (68 patients)
Trial: 7840553
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of dapsone and rifampin
Trial: 7840553
Drug: Four-drug regimen
RxNorm normalized name: Four-Way
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Four-drug regimen (dapsone, rifampin, isoniazid, prothionamide)
Trial: 3281706
Drug: 1% silver
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% silver sulphadiazine ophthalmic ointment
Trial: 31144590
Drug: External beam
RxNorm normalized name: Beam
DrugBank: Tricyclazole (DB02891)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: External beam radiation therapy plus brachytherapy
Trial: 31144590
Drug: Radical prostatectomy
RxNorm normalized name: Campsis radicans flower extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radical prostatectomy plus adjuvant radiation therapy
Trial: 27284754
Drug: High protein
RxNorm normalized name: Vital High Protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High protein intake (HPI; 0.6 g•kg‐1•bolus‐1)
Trial: 27284754
Drug: Moderate protein
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate protein intake (MPI; 0.3 g•kg‐1•bolus‐1)
Trial: 17712241
Drug: One-session HIV
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: One-session HIV risk-reduction intervention during 16 weeks of outpatient cognitive behavioral SUD treatment
Trial: 15121556
Drug: Misoprostol 800
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Misoprostol 800 microg vaginally 6 to 8 hours after mifepristone 200 mg
Trial: 15121556
Drug: Misoprostol 800
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Misoprostol 800 microg vaginally 23 to 25 hours after mifepristone 200 mg
Trial: 2525329
Drug: Nicorandil 5
RxNorm normalized name: nicorandil 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicorandil 5 mg twice daily
Trial: 2525329
Drug: Nicorandil 10
RxNorm normalized name: nicorandil 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicorandil 10 mg twice daily
Trial: 16513448
Drug: Grapefruit juice
RxNorm normalized name: grapefruit juice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Grapefruit juice (300 mL daily for 10 days)
Trial: 16513448
Drug: Ritonavir (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ritonavir (400 mg daily for 10 days)
Trial: 16513448
Drug: Water (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Water (300 mL daily for 10 days)
Trial: 8937535
Drug: Lamotrigine (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lamotrigine (75 to 400 mg daily)
Trial: 1569602
Drug: MTP‐PE 1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MTP‐PE 1 mg
Trial: 1569602
Drug: MTP‐PE 4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MTP‐PE 4 mg
Trial: 31425441
Drug: Mycophenolate mofetil
RxNorm normalized name: Mycophenolate Mofetil
DrugBank: Mycophenolate mofetil (DB00688)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mycophenolate mofetil (MMF), mean daily dose 927 ± 209 mg/m²
Trial: 27221208
Drug: IV brivaracetam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV brivaracetam (BRV) administered as a bolus (200 mg/day BID)
Trial: 27221208
Drug: IV brivaracetam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV brivaracetam (BRV) administered as an infusion (200 mg/day BID)
Trial: 27221208
Drug: Oral brivaracetam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral brivaracetam (BRV) (200 mg/day)
Trial: 27221208
Drug: IV brivaracetam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV brivaracetam (BRV) (bolus or infusion)
Trial: 14555369
Drug: Medicine for
RxNorm normalized name: IBUPROFEN 200 mg ORAL TABLET [Ibuprofen Fast relief medicine for pain]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medicine for headache
Trial: 14555369
Drug: Medicine for
RxNorm normalized name: IBUPROFEN 200 mg ORAL TABLET [Ibuprofen Fast relief medicine for pain]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medicine for stomach ache
Trial: 14555369
Drug: Reported medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reported medicine use trend
Trial: 14555369
Drug: Frequent users
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Frequent users of medicine
Trial: 8606475
Drug: Ibuprofen (three
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen (three doses: 10 mg/kg intravenously followed by 5 mg/kg at 24 and 48 hours; n = 12)
Trial: 8606475
Drug: Ibuprofen (one
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen (one dose: 10 mg/kg intravenously; n = 11)
Trial: 8606475
Drug: Ibuprofen (three
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen (three doses)
Trial: 6775327
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg d-amphetamine
Trial: 21497767
Drug: l-carnitine 50
RxNorm normalized name: L-Carnitine 500mg Oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: l-carnitine 50 mg/kg body weight PO
Trial: 1312907
Drug: Glutathione (GSH,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glutathione (GSH, 2.5 g given i.v.) pretreatment prior to cisplatin infusion
Trial: 1312907
Drug: Cisplatin (CDDP,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisplatin (CDDP, 80 mg/m2) alone
Trial: 1312907
Drug: Cisplatin (CDDP,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisplatin (CDDP, 80 mg/m2) with GSH pretreatment
Trial: 3899093
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg purified porcine relaxin vaginally applied on the day of embryo transfer and again 3 days later
Trial: 3899093
Drug: Concurrent treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent treatment outside the trial (not specified)
Trial: 31613356
Drug: IGMKK16E7 low-dose
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: IGMKK16E7 low-dose (0.5 g/day)
Trial: 31613356
Drug: IGMKK16E7 middle-dose
RxNorm normalized name: WHEAT MIDDLINGS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IGMKK16E7 middle-dose (1 g/day)
Trial: 31613356
Drug: IGMKK16E7 high-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IGMKK16E7 high-dose (1.5 g/day)
Trial: 19731310
Drug: Urodynamics (UDS)
RxNorm normalized name: sucralfate
DrugBank: Sucralfate (DB00364)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Urodynamics (UDS) treatment
Trial: 19731310
Drug: Conservative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conservative treatment based on symptoms alone
Trial: 18786316
Drug: Multiple daily
RxNorm normalized name: Multivitamin Oral Tablet [MULTIPLE DAILY W/BETA]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple daily insulin injection (MDI)
Trial: 8676535
Drug: Oral meal
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral meal
Trial: 1611137
Drug: ponalrestat 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ponalrestat 600 mg per day
Trial: 31116891
Drug: Subcutaneous oxytocin
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Subcutaneous oxytocin (4 µg/4 ml saline)
Trial: 31116891
Drug: Subcutaneous lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Subcutaneous lidocaine 1% (4 ml)
Trial: 26265099
Drug: High-dose methotrexate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose methotrexate (HDMTX) treatment
Trial: 16088180
Drug: Dye-enhanced laser
RxNorm normalized name: amaranth dye
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dye-enhanced laser ablation (DLA) using a low-power diode laser at 10 W with ICG concentration of 0.5 mg/ml.
Trial: 12391535
Drug: Desflurane anaesthesia
RxNorm normalized name: Desflurane
DrugBank: Desflurane (DB01189)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Desflurane anaesthesia supplemented by 2 mg tropisetron
Trial: 10423055
Drug: Twice-daily morphine
RxNorm normalized name: clindamycin
DrugBank: Clindamycin (DB01190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Twice-daily morphine sulphate controlled-release suppositories
Trial: 10423055
Drug: Once-daily morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-daily morphine sulphate controlled-release suppositories
Trial: 7582383
Drug: Oral methylergometrine
RxNorm normalized name: methylergometrine
DrugBank: Methylergometrine (DB00353)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral methylergometrine (0.125 mg)
Trial: 7582383
Drug: Intravenous methylergometrine
RxNorm normalized name: methylergometrine
DrugBank: Methylergometrine (DB00353)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous methylergometrine (0.200 mg)
Trial: 1648886
Drug: Ofloxacin administration
RxNorm normalized name: Ofloxacin
DrugBank: Ofloxacin (DB01165)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ofloxacin administration
Trial: 21760499
Drug: Acetaminophen ER
RxNorm normalized name: acetaminophen Extended Release Oral Tablet
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen ER 1300 mg
Trial: 16022852
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg of DMPA from a multidose vial (400 mg/mL)
Trial: 16022852
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg of DMPA from a single-unit-dose vial (150 mg/mL)
Trial: 16022852
Drug: Unit-dose group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unit-dose group
Trial: 12221311
Drug: Psychoeducational intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Psychoeducational intervention (culturally sensitive group program in addition to individual supportive therapy)
Trial: 12221311
Drug: Individual supportive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Individual supportive therapy (control group)
Trial: 9697820
Drug: Fluvastatin (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin (40 mg twice daily) with L‐NMMA (4 micromol/min)
Trial: 8590530
Drug: Fibrate therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fibrate therapy (gemfibrozil 900 mg/day, ciprofibrate 100 mg/day, bezafibrate 400 mg/day, fenofibrate 300 or 400 mg/day)
Trial: 394300
Drug: Atropine (0.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atropine (0.6 mg) and meperidine (1 mg/kg body weight)
Trial: 394300
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (benzocaine and intravenous diazepam only)
Trial: 31108564
Drug: Usual care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual care medication review (Control)
Trial: 28771379
Drug: VR plus
RxNorm normalized name: Prostin VR
DrugBank: Alprostadil (DB00770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: VR plus standard treatment group
Trial: 28771379
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment (ST) group
Trial: 22260837
Drug: 3d triple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3d triple therapy (rabeprazole 10mg + furazolidone 100mg + clarithromycin 250mg for 3 days)
Trial: 22260837
Drug: 5d triple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5d triple therapy (rabeprazole 10mg + furazolidone 100mg + clarithromycin 250mg for 5 days)
Trial: 22260837
Drug: 7d triple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7d triple therapy (rabeprazole 10mg + furazolidone 100mg + clarithromycin 250mg for 7 days)
Trial: 19711845
Drug: Viferon (suppositories
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Viferon (suppositories of human recombinant interferon alfa‐2)
Trial: 19711845
Drug: Arbidol (reference
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Arbidol (reference drug)
Trial: 11219471
Drug: Telmisartan (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telmisartan (40 mg titrated to 80 mg titrated to 120 mg)
Trial: 11219471
Drug: Atenolol (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol (50 mg titrated to 100 mg)
Trial: 9482510
Drug: Buflomedil 400
RxNorm normalized name: buflomedil
DrugBank: Buflomedil (DB13510)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buflomedil 400 mg intravenous daily for 5 days
Trial: 3132275
Drug: Atropine (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atropine (30 micrograms/kg intravenous)
Trial: 26377553
Drug: Physical activity
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physical activity in daily living
Trial: 23929355
Drug: multifaceted intervention:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: multifaceted intervention: team‐based supported employment, systematic medication management, and other behavioral health services
Trial: 8452185
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg of fleroxacin orally
Trial: 8452185
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg of fleroxacin intravenously
Trial: 8452185
Drug: Dose adjustment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dose adjustment recommended for patients with renal disease (GFR < 40 mL/min)
Trial: 22715865
Drug: ACAT-initiated pharmacist
RxNorm normalized name: calcium acetate
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ACAT-initiated pharmacist home medicines review (APHMR)
Trial: 22715865
Drug: Feedback from
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Feedback from GPs on pharmacist medication reviews
Trial: 22715865
Drug: ACAT clinician
RxNorm normalized name: DuoCare Clinical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACAT clinician feedback on pharmacist-led medication review
Trial: 18705531
Drug: Val/HCTZ 320/25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Val/HCTZ 320/25 mg
Trial: 18705531
Drug: Val/HCTZ 320/12.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Val/HCTZ 320/12.5 mg
Trial: 18705531
Drug: Val 320
RxNorm normalized name: Val
DrugBank: Valine (DB00161)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Val 320 mg
Trial: 12518369
Drug: Liposomal amphotericin
RxNorm normalized name: Liposomal amphotericin B
DrugBank: Amphotericin B (DB00681)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Liposomal amphotericin B (L-AmB) 3 mg/kg intravenously 3 times per week
Trial: 12518369
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of fluconazole (200 mg orally every 12 hours) and itraconazole (200 mg orally every 12 hours)
Trial: 1437427
Drug: Parental worry
RxNorm normalized name: C.I. direct red 28 parent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parental worry about vaccine side effects
Trial: 31175716
Drug: Steam inhalation
RxNorm normalized name: Leader Hot Steam Inhalation Liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steam inhalation at 42-44°C
Trial: 19936714
Drug: d-amphetamine (0,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: d-amphetamine (0, 5, 10, and 20 mg)
Trial: 7984694
Drug: Lisuride 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lisuride 1.0 mg daily dose
Trial: 2500195
Drug: Midazolam (continuous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam (continuous intravenous infusion of 0.01‐0.20 mg/kg/h)
Trial: 31427860
Drug: Exercise (resistance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise (resistance exercise plus walking, 2 times weekly for 6 months)
Trial: 22340518
Drug: Pioglitazone (dose-escalation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pioglitazone (dose-escalation for three days followed by maintenance dose)
Trial: 21223254
Drug: Dipyridamole added
RxNorm normalized name: Dipyridamole
DrugBank: Dipyridamole (DB00975)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dipyridamole added to aspirin
Trial: 16685221
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy for blood pressure lowering
Trial: 16685221
Drug: Single-drug therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-drug therapy
Trial: 8237398
Drug: Metoprolol sustained-release
RxNorm normalized name: metoprolol Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol sustained-release tablets (Sino-Swed Pharmaceutical Co Ltd)
Trial: 8237398
Drug: Metoprolol tablets
RxNorm normalized name: metoprolol Oral Tablet
DrugBank: Metoprolol (DB00264)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Metoprolol tablets from Sweden Astra International Pharmaceutical Co Ltd
Trial: 22295543
Drug: Ringer solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ringer solution and 10% glucose solution in 1:1 ratio
Trial: 22295543
Drug: Sterofundin-G-5 solution
RxNorm normalized name: glutamine
DrugBank: L-Glutamine (DB00130)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sterofundin-G-5 solution
Trial: 22295543
Drug: Remaxol (800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remaxol (800 ml/day)
Trial: 10869286
Drug: Steroids (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroids (40 mg/d prednisolone)
Trial: 3517407
Drug: Aztreonam (AZT)
RxNorm normalized name: Aztreonam
DrugBank: Aztreonam (DB00355)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aztreonam (AZT) 1 g, twice a day by intravenous drip infusion for 5 days
Trial: 3517407
Drug: Cefoperazone (CPZ)
DrugBank: Cefoperazone (DB01329)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefoperazone (CPZ) 1 g, twice a day by intravenous drip infusion for 5 days
Trial: 29898619
Drug: Obinutuzumab plus
RxNorm normalized name: Obinutuzumab
DrugBank: Obinutuzumab (DB08935)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Obinutuzumab plus bendamustine (G + B) for up to 2 years
Trial: 29898619
Drug: Bendamustine monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bendamustine monotherapy (B-monotherapy)
Trial: 22688600
Drug: Cognitive-behavioral therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral therapy for pain
Trial: 18929283
Drug: Saline solution
RxNorm normalized name: Unisol 4 Saline Solution
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline solution (group C, n = 20)
Trial: 2646895
Drug: Simvastatin 40
RxNorm normalized name: simvastatin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin 40 mg once daily
Trial: 17262143
Drug: experimental agent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: experimental agent DD‐1
Trial: 17262143
Drug: experimental agent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: experimental agent DD‐2
Trial: 30221194
Drug: GLA-AF (aqueous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GLA-AF (aqueous formulation of glucopyranosyl lipid adjuvant)
Trial: 22472173
Drug: Intramuscular delivery
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular delivery of 40 ml bone marrow cells (n = 21)
Trial: 22472173
Drug: Intra-arterial delivery
RxNorm normalized name: methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intra-arterial delivery of 40 ml bone marrow cells (n = 20)
Trial: 19919585
Drug: MgSO(4) 60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MgSO(4) 60 mg/kg
Trial: 18625536
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg NA/5 microg EE
Trial: 18625536
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg NA/10 microg EE
Trial: 11809593
Drug: Finasteride 1
RxNorm normalized name: finasteride 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Finasteride 1 mg/day for one year
Trial: 10518297
Drug: 4-week lumbar
RxNorm normalized name: milnacipran
DrugBank: Milnacipran (DB04896)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 4-week lumbar stabilization exercise program with weekly reinstruction
Trial: 28375035
Drug: Esmolol (5-10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esmolol (5-10 µg/kg/min) in combination with propofol and remifentanil